← FDA Drug Approvals (Drugs@FDA)
BAXDELA
NDA · New Drug Application · Sponsor: MELINTA · Approved 2017-06-19
Drug application
- FDA Application #
NDA208610- Application type
- New Drug Application
- Brand name
- BAXDELA
- Generic name
- DELAFLOXACIN MEGLUMINE
- Active ingredients
- DELAFLOXACIN MEGLUMINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- MELINTA
- Manufacturer
- Melinta Therapeutics, LLC
- First approval
- 2017-06-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown